MedAssets (MDAS) Inactive 10-Q7 Nov 132013 Q3 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
Document and Entity Information	Sep. 30, 2013	Oct. 24, 2013
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'
Entity Registrant Name	'MEDASSETS INC	'
Entity Central Index Key	'0001254419	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	61,868,839

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Current assets	'	'
Cash and cash equivalents	$0	$13,734
Accounts receivable, net of allowances of $2,518 and $3,046 as of September 30, 2013 and December 31, 2012, respectively	91,152	96,346
Deferred tax asset, current portion	10,579	11,126
Prepaid expenses and other current assets	24,906	21,791
Total current assets	126,637	142,997
Property and equipment, net	155,485	134,361
Other long term assets	'	'
Goodwill	1,027,847	1,027,847
Intangible assets, net	282,206	330,163
Other	42,431	42,869
Other long term assets	1,352,484	1,400,879
Total assets	1,634,606	1,678,237
Current liabilities	'	'
Accounts payable	17,028	25,487
Accrued revenue share obligation and rebates	78,379	74,274
Accrued payroll and benefits	32,734	40,085
Other accrued expenses	23,562	14,145
Deferred revenue, current portion	51,758	55,756
Current portion of notes payable	15,500	15,500
Current portion of finance obligation	249	233
Total current liabilities	219,210	225,480
Notes payable, less current portion	452,875	544,500
Bonds payable	325,000	325,000
Finance obligation, less current portion	8,849	9,046
Deferred revenue, less current portion	14,960	14,393
Deferred tax liability	124,778	125,394
Other long term liabilities	10,119	801
Total liabilities	1,155,791	1,244,614
Commitments and contingencies	'	'
Stockholders' equity	'	'
Common stock, $0.01 par value, 150,000,000 shares authorized; 61,826,000 and 59,324,000 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	618	593
Additional paid-in capital	713,908	688,431
Accumulated deficit	-235,711	-255,401
Total stockholders' equity	478,815	433,623
Total liabilities and stockholders' equity	$1,634,606	$1,678,237

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Statement Of Financial Position [Abstract]	'	'
Allowances on accounts receivable	$2,518	$3,046
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	61,826,000	59,324,000
Common stock, shares outstanding	61,826,000	59,324,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenue:	'	'	'	'
Administrative fees, net	$69,426	$68,641	$216,447	$200,752
Other service fees	96,945	94,800	293,503	275,589
Total net revenue	166,371	163,441	509,950	476,341
Operating expenses:	'	'	'	'
Cost of revenue (inclusive of certain amortization expense)	38,246	34,570	110,010	100,583
Product development expenses	7,173	7,217	23,649	20,777
Selling and marketing expenses	12,898	12,983	46,925	46,709
General and administrative expenses	59,095	55,167	174,914	165,577
Acquisition and integration-related expenses	111	1,535	9,576	4,812
Depreciation	10,926	7,721	29,979	21,416
Amortization of intangibles	15,341	17,840	47,957	55,251
Total operating expenses	143,790	137,033	443,010	415,125
Operating income	22,581	26,408	66,940	61,216
Other income (expense):	'	'	'	'
Interest (expense)	-11,814	-16,672	-35,544	-50,722
Other income	118	114	435	449
Income before income taxes	10,885	9,850	31,831	10,943
Income tax expense	3,983	4,386	12,141	3,467
Net income	$6,902	$5,464	$19,690	$7,476
Basic and diluted income per share:	'	'	'	'
Basic net income per share	$0.12	$0.09	$0.33	$0.13
Diluted net income per share	$0.11	$0.09	$0.32	$0.13
Weighted average shares-basic	59,936	57,693	59,446	57,239
Weighted average shares-diluted	61,476	59,513	60,912	58,896

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Statement Of Income And Comprehensive Income [Abstract]	'	'	'	'
Net income	$6,902	$5,464	$19,690	$7,476
Unrealized loss from hedging activities for the period	'	-284	'	-1,442
Income tax expense related to hedging activities for the period	'	106	'	521
Comprehensive income	$6,902	$5,286	$19,690	$6,555

Condensed_Consolidated_Stateme2

Condensed Consolidated Statement of Stockholders' Equity (USD $)	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]
In Thousands, except Share data	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]
Balances at Dec. 31, 2012	$433,623	$593	$688,431	($255,401)
Balances, Shares at Dec. 31, 2012	'	59,324,000	'	'
Issuance of common stock from stock option and SSAR exercises and restricted stock issuances, net	9,911	25	9,886	'
Issuance of common stock from stock option and SSAR exercises and restricted stock issuances, net, Shares	'	2,502,000	'	'
Stock compensation expense	11,783	'	11,783	'
Excess tax benefit from equity award exercises, net	3,808	'	3,808	'
Net income	19,690	'	'	19,690
Balances at Sep. 30, 2013	$478,815	$618	$713,908	($235,711)
Balances, Shares at Sep. 30, 2013	'	61,826,000	'	'

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Operating activities	'	'
Net income	$19,690	$7,476
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:	'	'
Bad debt expense	'	485
Depreciation	31,719	22,769
Amortization of intangibles	47,957	55,668
Impairment of assets	2,403	'
(Gain) loss on sale of assets	-123	370
Noncash stock compensation expense	11,783	7,796
Excess tax benefit from exercise of equity awards	-5,091	-1,191
Amortization of debt issuance costs	2,858	5,705
Noncash interest expense, net	349	392
Deferred income tax benefit	-69	-441
Changes in assets and liabilities:	'	'
Accounts receivable	5,494	8,670
Prepaid expenses and other assets	-3,115	-2,600
Other long-term assets	-1,061	1,846
Accounts payable	-4,651	-4,477
Accrued revenue share obligations and rebates	4,105	572
Accrued payroll and benefits	-7,351	-4,294
Other accrued expenses and long-term liabilities	8,357	6,325
Deferred revenue	-3,431	2,610
Cash provided by operating activities	109,823	107,681
Investing activities	'	'
Purchases of property, equipment and software, net	-16,259	-11,779
Capitalized software development costs	-30,168	-31,045
Cash used in investing activities	-46,427	-42,824
Financing activities	'	'
Borrowings from revolving credit facility	'	90,000
Repayment of notes payable	-91,625	-94,763
Repayment of finance obligations	-507	-507
Payment of deferred purchase consideration	'	-120,136
Excess tax benefit from exercise of equity awards	5,091	1,191
Issuance of common stock, net of offering costs	9,911	5,245
Purchase of treasury shares	'	-600
Cash used in financing activities	-77,130	-119,570
Net decrease in cash and cash equivalents	-13,734	-54,713
Cash and cash equivalents, beginning of period	13,734	62,947
Cash and cash equivalents, end of period	$0	$8,234

Business_Description_and_Basis

Business Description and Basis of Presentation	9 Months Ended
	Sep. 30, 2013
Accounting Policies [Abstract]	'
Business Description and Basis of Presentation	'
	1	BUSINESS DESCRIPTION AND BASIS OF PRESENTATION
	We provide technology-enabled products and services which together deliver solutions designed to improve operating margin and cash flow for hospitals, health systems and other ancillary healthcare providers. Our client-specific solutions are designed to efficiently analyze detailed information across the spectrum of revenue cycle and spend management processes. Our solutions integrate with existing operations and enterprise software systems of our clients and provide financial improvement with minimal upfront costs or capital expenditures. Our operations and clients are primarily located throughout the United States and to a lesser extent, Canada.
	The accompanying unaudited Condensed Consolidated Financial Statements, and Condensed Consolidated Balance Sheet as of December 31, 2012, derived from audited financial statements, have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial reporting and as required by Regulation S-X, Rule 10-01 of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, certain information and footnote disclosures required for complete financial statements are not included herein. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation of the interim financial information have been included. When preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures at the date of the financial statements. Actual results could differ materially from those estimates. Operating results for the three and nine months ended September 30, 2013 are not necessarily indicative of the results that may be expected for any other interim period or for the fiscal year ending December 31, 2013.
	The accompanying unaudited Condensed Consolidated Financial Statements and notes thereto should be read in conjunction with the audited Consolidated Financial Statements for the year ended December 31, 2012 included in our Form 10-K as filed with the SEC on February 27, 2013 in addition to our Form 10-Q filed for periods after December 31, 2012. These financial statements include the accounts of MedAssets, Inc. and our wholly owned subsidiaries. All significant intercompany accounts have been eliminated in consolidation.
	Use of Estimates
	The preparation of the financial statements and related disclosures in conformity with GAAP and pursuant to the rules and regulations of the SEC, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ materially from those estimates. We believe that the estimates, assumptions and judgments involved in revenue recognition, allowances for doubtful accounts and returns, product development costs, share-based payments, business combinations, impairment of goodwill, intangible assets and long-lived assets, and accounting for income taxes have the greatest potential impact on our condensed consolidated financial statements.
	Cash and Cash Equivalents
	All of our highly liquid investments with original maturities of three months or less at the date of purchase are carried at cost which approximates fair value and are considered to be cash equivalents. Currently, our excess cash is voluntarily used to repay our swing-line credit facility, if any, on a daily basis and applied against our revolving credit facility on a routine basis when our swing-line credit facility is undrawn. In addition, we may periodically make voluntary repayments on our term loans. Cash and cash equivalents were zero and $13,734 as of September 30, 2013 and December 31, 2012, respectively, and our swing-line balance was zero during those reporting periods. We had $10,000 outstanding on our revolving credit facility as of September 30, 2013 and December 31, 2012. In the event our cash balance is zero at the end of a period, any outstanding checks are recorded as accrued expenses. As of September 30, 2013, we reclassified approximately $4,686 of outstanding checks related to a book overdraft into other accrued expenses on the condensed consolidated balance sheet. This book overdraft amount has been included in operating activities within the condensed consolidated statement of cash flows. See Note 5 for immediately available cash under our revolving credit facility.

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	9 Months Ended
	Sep. 30, 2013
Accounting Changes And Error Corrections [Abstract]	'
Recent Accounting Pronouncements	'
	2	RECENT ACCOUNTING PRONOUNCEMENTS
	Income Taxes
	In July 2013, the Financial Accounting Standards Board (“FASB”) issued an accounting standard update relating to the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This update amends existing GAAP that required in certain cases, an unrecognized tax benefit, or portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward when such items exist in the same taxing jurisdiction. The amendments in this update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. Early adoption is permitted. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date, and retrospective application is permitted. We do not expect any impact from this update on our financial statements.
	Comprehensive Income
	In February 2013, the FASB issued an accounting standard update relating to improving the reporting of reclassifications out of accumulated other comprehensive income. The update would require an entity to report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income if the amount being reclassified is required under GAAP to be reclassified in its entirety to net income. For other amounts that are not required under GAAP to be reclassified in their entirety to net income in the same reporting period, an entity is required to cross-reference other disclosures required under GAAP that provide additional detail about those amounts. The update is effective for reporting periods beginning after December 15, 2012. We adopted this update on January 1, 2013.

Acquisition_and_IntegrationRel

Acquisition and Integration-Related Expenses	9 Months Ended
Acquisition and Integration-Related Expenses	Sep. 30, 2013
Text Block [Abstract]	'
Acquisition and Integration-Related Expenses	'
	3	ACQUISITION AND INTEGRATION-RELATED EXPENSES
	Broadlane Acquisition
	In January 2012, we paid the deferred purchase consideration amount of $120,136 to Broadlane Holdings, LLC in connection with the acquisition of Broadlane Intermediate Holdings, Inc. (“Broadlane”).
	Restructuring Activities
	In connection with certain business activities, our management approved and initiated several plans to restructure our operations resulting in certain management, system and organizational changes within our Spend and Clinical Resource Management (“SCM”), Revenue Cycle Management (“RCM”) and corporate segments. During the three months ended September 30, 2013 and 2012, we expensed restructuring and exit and integration related costs of approximately $111 and $1,535, respectively. During the nine months ended September 30, 2013 and 2012, we expensed restructuring and exit and integration related costs of approximately $9,576 and $4,812, respectively. These costs were attributable to management changes and restructuring activities related to the Broadlane acquisition consisting of employee costs, system migration and standardization, facilities consolidation and other restructuring and integration costs. These costs are included within the acquisition and integration-related expenses line on the accompanying condensed consolidated statements of operations and comprehensive income.
	As of September 30, 2013, the components of our restructuring plans are as follows:

		—		Employee-related costs — during the three months ended September 30, 2013, we expensed approximately $570 of cash-based compensation and $920 of share-based compensation related to the resignation of our RCM segment president on September 30, 2013. During the three months ended September 30, 2012, we expensed approximately $738 of employee-related costs. During the nine months ended September 30, 2013 and 2012, we expensed approximately $807 and $2,587 of employee-related costs, respectively. The costs primarily related to severance, salaries relating to redundant positions, certain bonuses and other employee benefits. As of September 30, 2013, we had approximately $697 included in current liabilities for these costs.

		—		System migration and standardization — during the three months ended September 30, 2013 and 2012, we expensed approximately $98 and $787 of system migration costs, respectively. During the nine months ended September 30, 2013 and 2012, we expensed approximately $2,372 and $2,175 of system migration costs, respectively. The costs primarily related to consulting and other third-party services. As of September 30, 2013, we had approximately $8 included in current liabilities for these costs. In addition, we had non-cash adjustments of ($389) for the write-off of impaired development projects related to the Broadlane acquisition.

		—		Facilities consolidation — in March 2013, we exited our existing SCM and RCM leased facilities in Plano, Texas and began occupying a new leased facility comprised of approximately 231,000 square feet of office space together with certain surface parking areas in Plano, Texas. The lease term of the new facility commenced on March 1, 2013 and has an initial term of fifteen years plus an option to extend the lease term for up to ten years. In connection with the lease, the landlord provided a tenant allowance that was used for certain improvements to the facility amounting to $10,378, with $9,974 included in property and equipment on our condensed consolidated balance sheet as of September 30, 2013. We had approximately $692 included in other accrued expenses and $9,282 included in other long term liabilities associated with this allowance as of September 30, 2013. The liability will be recognized ratably as a reduction to rent expense over the term of the lease. We did not receive or pay any cash related to the tenant allowance and therefore the amount is not reflected in our condensed consolidated statement of cash flows for the nine months ended September 30, 2013.

	In March 2013, we expensed approximately $6,924, relating to exit costs to vacate our previous SCM and RCM leased facilities in Plano, Texas. In August 2013, we amended the lease agreement for the previous RCM facility to accelerate the expiration date to August 2013 from its original expiration of January 2022 to effectively terminate the lease. As a result, we paid a lease termination fee of $6,000 and adjusted our total exit cost estimate associated with this lease liability by ($557) from what was originally estimated. As a result of the termination, we have no further obligation related to this lease agreement.
	During the nine months ended September 30, 2013, we expensed approximately $6,397, relating to exit costs to vacate our previous SCM and RCM leased facilities in Plano, Texas as previously discussed. In addition, we had non-cash adjustments of $613 comprised of: (i) accrued rent of $1,669 related to the previously leased facilities; and (ii) the write-off of certain related facility assets of ($1,056).
	The following table summarizes the details of the Company’s restructuring activities during the nine months ended September 30, 2013:


			Employee-related		System migration		Facility		Total
			costs		and integration		consolidation		Total
	Restructuring Reserve
	Accrued, December 31, 2012		$	995	$	305	$	132	$	1,432
	Charges incurred			807		2,372		6,397		9,576
	Adjustments			-		(389)		613		224
	Cash payments			(1,105)		(2,280)		(7,142)		(10,527)

	Accrued, September 30, 2013		$	697	$	8	$	-	$	705	(1)


		-1	The remaining restructuring accrual consists primarily of employee-related costs and will be paid over the next twelve months.

Deferred_Revenue

Deferred Revenue	9 Months Ended
Deferred Revenue	Sep. 30, 2013
Revenue Recognition [Abstract]	'
Deferred Revenue	'
	4	DEFERRED REVENUE
	Deferred revenue consists of unrecognized revenue related to advanced client billing or client payments received prior to revenue being realized and earned. Substantially all of our deferred revenue consists of: (i) deferred administrative fees, net; (ii) deferred service fees; (iii) deferred software and implementation fees; and (iv) other deferred fees, including receipts for our annual customer and vendor meeting prior to the event.
	The following table summarizes the deferred revenue categories and balances as of:


			September 30,		December 31,
			2013		2012
	Software and implementation fees		$	26,313	$	24,468
	Service fees			28,890		26,135
	Administrative fees			9,353		14,672
	Other fees			2,162		4,874

	Deferred revenue, total			66,718		70,149
	Less: Deferred revenue, current portion			(51,758)		(55,756)

	Deferred revenue, non-current portion		$	14,960	$	14,393

	As of September 30, 2013 and December 31, 2012, deferred revenue included in our condensed consolidated balance sheets that was contingent upon meeting performance targets was $8,318 and $8,284, respectively. Advance billings on arrangements that include contingent performance targets are recorded in accounts receivable and deferred revenue when billed. Only certain contingent performance targets are billed in advance of meeting the target as determined by the customer arrangement.

Notes_and_Bonds_Payable

Notes and Bonds Payable	9 Months Ended
Notes and Bonds Payable	Sep. 30, 2013
Debt Disclosure [Abstract]	'
Notes and Bonds Payable	'
	5. NOTES AND BONDS PAYABLE
	The balances of our notes and bonds payable are summarized as follows as of:


			September 30,		December 31,
			2013		2012
	Term A facility		$	240,625	$	250,000
	Term B facility			217,750		300,000
	Revolving credit facility			10,000		10,000

	Total notes payable			468,375		560,000
	Bonds payable			325,000		325,000

	Total notes and bonds payable			793,375		885,000
	Less: current portions			(15,500)		(15,500)

	Total long-term notes and bonds payable		$	777,875	$	869,500

	Notes Payable
	As of September 30, 2013, our long-term notes payable consists of a Term A Facility, a Term B Facility and a revolving credit facility, each with an outstanding balance of $240,625, $217,750 and $10,000, respectively. We have classified the $10,000 outstanding balance on our revolving credit facility as a long term liability given the maturity date of December 13, 2017. No amounts were drawn on our swing line loan, which resulted in approximately $189,000 of availability under our revolving credit facility inclusive of the swing line (after giving effect to $1,000 of outstanding but undrawn letters of credit on such date) as of September 30, 2013. During the nine months ended September 30, 2013, we made scheduled principal payments of $11,625 on our Term A and Term B Facility in addition to $80,000 in voluntary prepayments from available free cash flow on our Term B Facility. The applicable weighted average interest rates (inclusive of the applicable bank margin) on our Term A Facility, Term B Facility and Revolving Credit Facility at September 30, 2013 were 2.53%, 4.00% and 2.52%, respectively.
	We are a party to a credit agreement with JP Morgan Chase Bank, N.A and other financial institutions named therein, dated December 13, 2012. The credit agreement contains certain customary negative covenants, including but not limited to, limitations on the incurrence of debt, limitations on liens, limitations on fundamental changes, limitations on asset sales and sale leasebacks, limitations on investments, limitations on dividends or distributions on, or redemptions of, equity interests, limitations on prepayments or redemptions of unsecured or subordinated debt, limitations on negative pledge clauses, limitations on transactions with affiliates and limitations on changes to the Company’s fiscal year. The credit agreement also includes maintenance covenants of maximum ratios of consolidated total indebtedness (subject to certain adjustments) to consolidated EBITDA (subject to certain adjustments) and minimum cash interest coverage ratios. The credit agreement contains certain customary representations and warranties, affirmative covenants and events of default, including but not limited to payment defaults, breaches of representations and warranties, covenant defaults, cross-defaults to certain indebtedness, certain events of insolvency or bankruptcy, material judgments, certain events under ERISA, actual or asserted failures of any guaranty or security document supporting the credit agreement to be in full force and effect and changes of control. The Company was in compliance with these covenants as of September 30, 2013.
	Loans under the credit agreement must be prepaid under certain circumstances, including with proceeds from certain future debt issuances, asset sales and a portion of excess cash flow for the applicable fiscal year. Our first excess cash flow calculation will be completed during the first quarter of 2014 for the fiscal year ended December 31, 2013. Loans under the credit agreement may be voluntarily prepaid at any time, subject to customary LIBOR breakage costs.
	Bonds Payable
	In November 2010, we closed the offering of an aggregate principal amount of $325,000 of senior notes due 2018 (the “Notes”) in a private placement (the “Notes Offering”). In October 2011, our Notes were registered under the Securities Act of 1933, as amended. The Notes are guaranteed on a senior unsecured basis by each of our existing domestic subsidiaries and each of our future domestic restricted subsidiaries in each case that guarantees our obligations under the credit agreement. Each of the subsidiary guarantors is 100% owned by us; the guarantees by the subsidiary guarantors are full and unconditional; the guarantees by the subsidiary guarantors are joint and several; we have no independent assets or operations; and any subsidiaries of ours other than the subsidiary guarantors are minor. The Notes and the guarantees are senior unsecured obligations of the Company and the subsidiary guarantors, respectively.
	The Notes were issued pursuant to an indenture dated as of November 16, 2010 (the “Indenture”) among the Company, its subsidiary guarantors and Wells Fargo Bank, N.A., as trustee. Pursuant to the Indenture, the Notes will mature on November 15, 2018 and bear 8% annual interest. Interest on the Notes is payable semi-annually in arrears on May 15 and November 15 of each year, beginning on May 15, 2011.
	The Indenture contains certain customary negative covenants, including but not limited to, limitations on the incurrence of debt, limitations on liens, limitations on consolidations or mergers, limitations on asset sales, limitations on certain restricted payments and limitations on transactions with affiliates. The Indenture does not contain any significant restrictions on the ability of the Company or any subsidiary guarantor to obtain funds from the Company or any other subsidiary guarantor by dividend or loan. The Indenture also contains customary events of default. The Company was in compliance with these covenants as of September 30, 2013.

	The Company has the option to redeem the Notes as follows: (i) at any time prior to November 15, 2014, the Company may redeem all or part of the Notes at a redemption price equal to 100% of the principal amount plus the applicable premium (as defined in the Indenture); (ii) at any time prior to November 15, 2013, the Company may redeem up to 35% of the aggregate principal amount of the Notes issued with the cash proceeds of one or more equity offerings at a redemption price of 108% of the principal amount, provided that: (A) at least 65% of the aggregate original principal amount of the Notes remains outstanding immediately after each such redemption; and (B) the redemption occurs within 60 days after the closing of such equity offering; and (iii) on and after November 15, 2014, the Company may redeem all or a part of the Notes, at the following redemption prices:


	Year		Percentage
	2014			104%
	2015			102%
	2016 and thereafter			100%
	The Notes also contain a redemption feature that would require the repurchase of 101% of the aggregate principal amount plus accrued and unpaid interest at the option of the holders upon a change in control.
	As of September 30, 2013, the Company’s 8% senior notes due 2018 were trading at 107.5% of par value (Level 1).
	Debt Issuance Costs
	As of September 30, 2013, we had approximately $18,214 of debt issuance costs related to our credit agreement and Notes which will be amortized into interest expense generally using the effective interest method until the applicable maturity date. For the three months ended September 30, 2013 and 2012, we recognized $951 and $1,914, respectively, in interest expense related to the amortization of debt issuance costs. For the nine months ended September 30, 2013 and 2012, we recognized $2,858 and $5,705, respectively, in interest expense related to the amortization of debt issuance costs.
	Debt Maturity Table
	The following table summarizes our stated debt maturities and scheduled principal repayments as of September 30, 2013:


	Year		Term A Facility		Term B Facility		Revolving Credit		Senior		Total
	Year		Term A Facility		Term B Facility		Facility		Unsecured Notes		Total
	2013		$	3,125	$	750	$	-	$	-	$	3,875	(1)
	2014			12,500		3,000		-		-		15,500
	2015			18,750		3,000		-		-		21,750
	2016			25,000		3,000		-		-		28,000
	2017			181,250		3,000		10,000		-		194,250
	Thereafter			-		205,000		-		325,000		530,000

			$	240,625	$	217,750	$	10,000	$	325,000	$	793,375


		-1	Represents the remaining quarterly principal payments due during the fiscal year ending December 31, 2013.
	Total interest paid (net of amounts capitalized) on our notes and bonds payable during the nine months ended September 30, 2013 and 2012 was approximately $28,038 and $37,563, respectively.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2013
Commitments And Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	6	COMMITMENTS AND CONTINGENCIES
	Performance Targets
	In the ordinary course of contracting with our clients, we may agree to make some or all of our fees contingent upon the client’s achievement of financial improvement targets from the use of our services and software. These contingent fees are not recognized as revenue until the client confirms achievement of the performance targets. We generally receive client acceptance as and when the performance targets are achieved. If we invoice contingent fees prior to client confirmation that a performance target has been achieved, we record invoiced contingent fees as deferred revenue on our condensed consolidated balance sheet. Often, recognition of this revenue occurs in periods subsequent to the recognition of the associated costs.

	Legal Proceedings
	From time to time, we become involved in legal proceedings arising in the ordinary course of business. As of September 30, 2013, we are not presently involved in any legal proceedings, the outcome of which, if determined adversely to us, would have a material adverse effect on our business, operating results or financial condition.

Stockholders_Equity_and_ShareB

Stockholders' Equity and Share-Based Compensation	9 Months Ended
Stockholders' Equity and Share-Based Compensation	Sep. 30, 2013
Text Block [Abstract]	'
Stockholders' Equity and Share-Based Compensation	'
	7	STOCKHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION
	Common Stock
	During the nine months ended September 30, 2013, we issued approximately 1,427,000 shares of common stock in connection with employee stock option and stock-settled stock appreciation right (or “SSAR”) exercises for net exercise proceeds of $9,911.
	Share-Based Compensation
	As of September 30, 2013, we had restricted common stock, SSARs and common stock option equity awards outstanding under three share-based compensation plans. As of September 30, 2013, we had approximately 4,955,000 shares reserved (inclusive of equity award forfeitures) and available for grant under the 2008 MedAssets, Inc. Long-Term Performance Incentive Plan (“LTPIP”). The increase in shares available for grant was primarily attributable to an amendment to our LTPIP that authorized for issuance an additional 2,600,000 shares. The amendment was approved during our annual stockholders meeting on June 13, 2013.
	The total share-based compensation expense related to equity awards was $4,361 and $2,781 for the three months ended September 30, 2013 and 2012, respectively. The total income tax benefit recognized in the condensed consolidated statement of operations for share-based compensation arrangements related to equity awards was $1,627 and $1,033 for the three months ended September 30, 2013 and 2012, respectively.
	The total share-based compensation expense related to equity awards was $11,783 and $7,796 for the nine months ended September 30, 2013 and 2012, respectively. The total income tax benefit recognized in the condensed consolidated statement of operations for share-based compensation arrangements related to equity awards was $4,396 and $2,895 for the nine months ended September 30, 2013 and 2012, respectively. There were no capitalized share-based compensation expenses during the three and nine months ended September 30, 2013.
	Total share-based compensation expense (inclusive of restricted common stock, SSARs and common stock options) for the three and nine months ended September 30, 2013 and 2012 as reflected in our condensed consolidated statements of operations is as follows:


			Three Months Ended September 30,					Nine Months Ended September 30,
			2013			2012		2013		2012
	Cost of revenue		$	864		$	672	$	3,040	$	1,535
	Product development			130			34		473		123
	Selling and marketing			975			282		1,944		1,069
	General and administrative			2,392			1,793		6,326		5,069

	Total share-based compensation expense		$	4,361	(1)	$	2,781	$	11,783	$	7,796


	-1	For the three months ended September 30, 2013, share-based compensation includes charges related to the resignation of our RCM president and the conformity of one officer’s terms and conditions to their 2013 performance award grant.
	Equity Award Expense Attribution
	In general, for equity awards with graded-vesting, compensation cost is recognized using an accelerated method over the vesting or service period and is net of estimated forfeitures. In general, for equity awards with cliff-vesting, compensation cost is recognized using a straight-line method over the vesting or service period and is net of estimated forfeitures. For performance-based equity awards, compensation cost is adjusted each reporting period in which a change in performance achievement is determined and is net of estimated forfeitures. We evaluate the probability of performance achievement each reporting period and, if necessary, adjust share-based compensation expense based on expected performance achievement.
	Employee Stock Purchase Plan
	In 2010, we established the MedAssets, Inc. Employee Stock Purchase Plan (the “Plan”). Under the Plan, eligible employees may purchase shares of our common stock at a discounted price through payroll deductions. The price per share of the common stock sold to participating employees will be 95% of the fair market value of our common stock on the applicable purchase date. The Plan requires that all stock purchased be held by participants for a period of 18 months from the purchase date. A total of 500,000 shares of our common stock are authorized for purchase under the Plan. For the nine months ended September 30, 2013 and 2012, we purchased approximately 24,700 shares and 25,400 shares of our common stock under the Plan which amounted to approximately $482 and $372, respectively.

	Equity Award Grants
	Information regarding equity awards for the nine months ended September 30, 2013 is as follows:
	Restricted Common Stock Awards
	In 2013, our Board of Directors and Compensation, Governance and Nominating Committee approved an equity grant for certain eligible employees consisting of service-based and performance-based restricted shares. The purpose of the equity grant is to assist the Company in attracting, retaining, motivating, and rewarding certain individuals of the Company. The equity grant is intended to promote the creation of long-term value for stockholders of the Company by closely aligning the interests of such individuals with those of the stockholders. The total approved equity grant amounted to approximately 1,160,000 restricted shares with a grant date fair value of $18.34 per share and was comprised of: (i) 50,000 service-based restricted shares that vest ratably each month through December 31, 2013; (ii) 435,000 service-based restricted shares that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2014; (iii) 337,500 performance-based restricted shares using a net revenue performance metric that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2014 provided the performance metric is achieved; and (iv) 337,500 performance-based restricted shares using an adjusted EBITDA performance metric that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2014 provided the performance metric is achieved.
	The measurement period for the net revenue performance-based awards is from January 1, 2013 through December 31, 2013. The net revenue performance metric is based on the achievement of an established net revenue target. The Company must achieve a minimum threshold of net revenue before any performance-based restricted shares begin vesting. The equity award holders have an opportunity to earn between 50% and 100% of the performance-based equity awards once the minimum threshold has been met. If the minimum threshold is not met, the equity award holders will forfeit those awards.
	The measurement period for the adjusted EBITDA performance-based awards is from January 1, 2013 through December 31, 2013. The adjusted EBITDA performance metric is based on the achievement of an established adjusted EBITDA target. The Company must achieve a minimum threshold of adjusted EBITDA before any performance-based restricted shares begin vesting. The equity award holders have an opportunity to earn between 50% and 100% of the performance-based equity awards once the minimum threshold has been met. If the minimum threshold is not met, the equity award holders will forfeit those awards.
	During the nine months ended September 30, 2013, an additional 38,000 service-based restricted shares were granted. The shares vest annually over three years with the first annual vest date beginning on June 1, 2014. The weighted average grant date fair value of each restricted common stock share was $20.03.
	During the nine months ended September 30, 2013, we received approximately 54,000 restricted shares that were surrendered from equity awards holders to settle their associated minimum statutory tax liability from shares that vested during the year.
	During the nine months ended September 30, 2013, approximately 69,000 shares of restricted common stock were forfeited.
	As of September 30, 2013, there was approximately $13,188 of total unrecognized compensation expense related to all unvested restricted common stock awards that will be recognized over a weighted-average period of 1.3 years.
	SSAR Awards
	During the nine months ended September 30, 2013, we granted approximately 3,000 SSARs which have a service vesting period of five years. The weighted-average grant date base price of each SSAR was $16.77 and the weighted-average grant date fair value of each SSAR granted during the nine months ended September 30, 2013 was $7.15.
	During the nine months ended September 30, 2013, approximately 245,000 SSARs were forfeited.
	As of September 30, 2013, there was approximately $3,179 of total unrecognized compensation expense related to all unvested SSARs that will be recognized over a weighted-average period of 1.6 years.

	Common Stock Option Awards
	During the nine months ended September 30, 2013, we did not grant any stock option awards.
	During the nine months ended September 30, 2013, approximately 58,000 stock option awards were forfeited.
	As of September 30, 2013, there was approximately $64 of total unrecognized compensation expense related to all outstanding stock option awards that will be recognized over a weighted-average period of 1 year.

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	8	INCOME TAXES
	Income tax expense recorded during the three and nine months ended September 30, 2013 reflected an effective income tax rate of 36.6% and 38.1%, respectively. Income tax expense recorded during the three and nine months ended September 30, 2012 reflected an effective income tax rate of 44.5% and 31.7%, respectively. During 2012, we restructured several subsidiaries to reflect the integration of the Broadlane acquisition into our operations. This restructuring required us to recognize a reduction in our state income tax rate and as a result, we recognized a $1,400 discrete tax benefit during the nine months ended September 30, 2012.

Income_Per_Share

Income Per Share	9 Months Ended
Income Per Share	Sep. 30, 2013
Earnings Per Share [Abstract]	'
Income Per Share	'
	9	INCOME PER SHARE
	We calculate earnings per share (or “EPS”) in accordance with GAAP relating to earnings per share. Basic EPS is calculated by dividing reported net income by the weighted-average number of common shares outstanding for the reported period following the two-class method. Diluted EPS reflects the potential dilution that could occur if our stock options, stock-settled stock appreciation rights, unvested restricted stock and stock warrants were exercised and converted into our common shares during the reporting periods.
	A reconciliation of basic and diluted weighted average shares outstanding for basic and diluted EPS for the three and nine months ended September 30, 2013 and 2012 is as follows:


			Three Months Ended September 30,
			2013		2012
	Numerator for Basic and Diluted Income Per Share:
	Net income			6,902		5,464
	Denominator for basic income per share weighted average shares			59,936,000		57,693,000
	Effect of dilutive securities:
	Stock options			529,000		999,000
	Stock-settled stock appreciation rights			406,000		96,000
	Restricted stock and stock warrants			605,000		725,000

	Denominator for diluted income per share—adjusted weighted average shares and assumed conversions			61,476,000		59,513,000
	Basic income per share:
	Basic net income from continuing operations		$	0.12	$	0.09

	Diluted net income per share:
	Diluted net income from continuing operations		$	0.11	$	0.09



			Nine Months Ended September 30,
			2013		2012
	Numerator for Basic and Diluted Income Per Share:
	Net income			19,690		7,476
	Denominator for basic income per share weighted average shares			59,446,000		57,239,000
	Effect of dilutive securities:
	Stock options			601,000		916,000
	Stock-settled stock appreciation rights			285,000		15,000
	Restricted stock and stock warrants			580,000		726,000

	Denominator for diluted income per share—adjusted weighted average shares and assumed conversions			60,912,000		58,896,000
	Basic income per share:
	Basic net income from continuing operations		$	0.33	$	0.13

	Diluted net income per share:
	Diluted net income from continuing operations		$	0.32	$	0.13

	During the three and nine months ended September 30, 2013 and 2012, the effect of certain dilutive securities have been excluded because the impact is anti-dilutive as a result of certain securities being “out of the money” with strike prices greater than the average market price during the periods presented.
	The following table provides a summary of those potentially dilutive securities that have been excluded from the above calculation of diluted EPS:


			Three Months Ended September 30,				Nine Months Ended September 30,
			2013		2012		2013		2012
	Stock options			-		40,000		-		70,000
	Stock-settled stock appreciation rights			8,000		386,000		37,000		830,000
	Restricted stock and stock warrants			-		-		1,000		3,000

	Total			8,000		426,000		38,000		903,000

Segment_Information

Segment Information	9 Months Ended
Segment Information	Sep. 30, 2013
Segment Reporting [Abstract]	'
Segment Information	'
	10. SEGMENT INFORMATION
	We manage our business through two reportable business segments, Spend and Clinical Resource Management (or “SCM”) and Revenue Cycle Management (or “RCM”).

		—		Spend and Clinical Resource Management. Our SCM segment provides a comprehensive suite of technology-enabled services that help our clients manage their expense categories. Our solutions lower supply and medical device pricing and utilization by managing the procurement process through our group purchasing organization (“GPO”) portfolio of contracts, consulting services and business intelligence tools.

		—		Revenue Cycle Management. Our RCM segment provides a comprehensive suite of software and services spanning the hospital, health system and other ancillary healthcare provider revenue cycle workflow — from patient admission and financial responsibility, patient financial liability estimation, charge capture, case management, contract management and health information management through claims processing and accounts receivable management. Our workflow solutions, together with our data management and business intelligence tools, increase revenue capture and cash collections, reduce accounts receivable balances and increase regulatory compliance.
	GAAP relating to segment reporting, defines reportable segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing financial performance. The guidance indicates that financial information about segments should be reported on the same basis as that which is used by the chief operating decision maker in the analysis of performance and allocation of resources. Management of the Company, including our chief operating decision maker, uses what we refer to as Segment Adjusted EBITDA as its primary measure of profit or loss to assess segment performance and to determine the allocation of resources. We define Segment Adjusted EBITDA as segment net income (loss) before net interest expense, income tax expense (benefit), depreciation and amortization (“EBITDA”) as adjusted for other non-recurring, non-cash or non-operating items. Our chief operating decision maker uses Segment Adjusted EBITDA to facilitate a comparison of our operating performance on a consistent basis from period to period. Segment Adjusted EBITDA includes expenses associated with sales and marketing, general and administrative and product development activities specific to the operation of the segment. General and administrative corporate expenses that are not specific to the segments are not included in the calculation of Segment Adjusted EBITDA. These expenses include the costs to manage our corporate offices, interest expense on our credit facilities and expenses related to being a publicly-held company. All reportable segment revenues are presented net of inter-segment eliminations and represent revenues from external clients.
	The following tables present Segment Adjusted EBITDA and financial position information as utilized by our chief operating decision maker. A reconciliation of Segment Adjusted EBITDA to consolidated net income is included. General corporate expenses are included in the “Corporate” column. “SCM” represents the Spend and Clinical Resource Management segment and “RCM” represents the Revenue Cycle Management segment. Other assets and liabilities are included to provide a reconciliation to total assets and total liabilities.
	The following tables represent our results of operations, by segment, for the three and nine months ended September 30, 2013 and 2012:


			Three Months Ended September 30, 2013
			SCM			RCM			Corporate			Total
	Results of Operations:
	Revenue:
	Gross administrative fees(1)		$	115,478		$	-		$	-		$	115,478
	Revenue share obligation(1)			(46,052)			-			-			(46,052)
	Other service fees			33,801			63,144			-			96,945

	Total net revenue			103,227			63,144			-			166,371
	Total operating expenses			74,381			56,016			13,393			143,790

	Operating income (loss)			28,846			7,128			(13,393)			22,581
	Interest expense			-			-			(11,814)			(11,814)
	Other (expense) income			1			7			110			118

	Income (loss) before income taxes		$	28,847		$	7,135		$	(25,097)		$	10,885
	Income tax expense (benefit)			10,599			2,584			(9,200)			3,983

	Net income (loss)			18,248			4,551			(15,897)			6,902

	Segment Adjusted EBITDA		$	47,387		$	15,349		$	(8,837)		$	53,899

		-1	These are non-GAAP measures. See “Use of Non-GAAP Financial Measures” section for additional information.


			As of September 30, 2013
			SCM			RCM			Corporate			Total
	Financial Position:
	Accounts receivable, net		$	39,489		$	51,647		$	16		$	91,152
	Other assets			965,833			503,063			74,558			1,543,454

	Total assets			1,005,322			554,710			74,574			1,634,606
	Accrued revenue share obligation			78,379			-			-			78,379
	Deferred revenue			25,424			41,294			-			66,718
	Notes payable			-			-			468,375			468,375
	Bonds payable			-			-			325,000			325,000
	Other liabilities			28,039			25,156			164,124			217,319

	Total liabilities		$	131,842		$	66,450		$	957,499		$	1,155,791


			Three Months Ended September 30, 2012
			SCM			RCM			Corporate			Total
	Results of Operations:
	Revenue:
	Gross administrative fees(1)		$	109,335		$	-		$	-		$	109,335
	Revenue share obligation(1)			(40,694)			-			-			(40,694)
	Other service fees			30,471			64,329			-			94,800

	Total net revenue			99,112			64,329			-			163,441
	Total operating expenses			72,715			53,082			11,236			137,033

Operating income (loss)			26,397			11,247			(11,236)			26,408
Interest expense			-			-			(16,672)			(16,672)
Other income			9			27			78			114

Income (loss) before income taxes		$	26,406		$	11,274		$	(27,830)		$	9,850
Income tax expense (benefit)			14,255			5,171			(15,040)			4,386

Net income (loss)			12,151			6,103			(12,790)			5,464

Segment Adjusted EBITDA		$	46,340		$	17,835		$	(7,210)		$	56,965

	-1	These are non-GAAP measures. See “Use of Non-GAAP Financial Measures” section for additional information.


		Nine Months Ended September 30, 2013
		SCM			RCM			Corporate			Total
Results of Operations:
Revenue:
Gross administrative fees(1)		$	351,602		$	-		$	-		$	351,602
Revenue share obligation(1)			(135,155)			-			-			(135,155)
Other service fees			101,596			191,907			-			293,503

Total net revenue			318,043			191,907			-			509,950
Total operating expenses			238,777			167,593			36,640			443,010

Operating income (loss)			79,266			24,314			(36,640)			66,940
Interest expense			-			-			(35,544)			(35,544)
Other (expense) income			(28)			(22)			485			435

Income (loss) before income taxes		$	79,238		$	24,292		$	(71,699)		$	31,831
Income tax expense (benefit)			30,222			9,266			(27,347)			12,141

Net income (loss)			49,016			15,026			(44,352)			19,690

Segment Adjusted EBITDA		$	144,041		$	47,061		$	(23,020)		$	168,082

	-1	These are non-GAAP measures. See “Use of Non-GAAP Financial Measures” section for additional information.


		Nine Months Ended September 30, 2012
		SCM			RCM			Corporate			Total
Results of Operations:
Revenue:
Gross administrative fees(1)		$	321,351		$	-		$	-		$	321,351
Revenue share obligation(1)			(120,599)			-			-			(120,599)
Other service fees			93,740			181,849			-			275,589

Total net revenue			294,492			181,849			-			476,341
Total operating expenses			220,938			161,273			32,914			415,125

Operating income (loss)			73,554			20,576			(32,914)			61,216
Interest expense			-			-			(50,722)			(50,722)
Other (expense) income			(12)			30			431			449

Income (loss) before income taxes		$	73,542		$	20,606		$	(83,205)		$	10,943
Income tax expense (benefit)			31,830			8,919			(37,282)			3,467

Net income (loss)			41,712			11,687			(45,923)			7,476

Segment Adjusted EBITDA		$	132,846		$	41,532		$	(22,001)		$	152,377

	-1	These are non-GAAP measures. See “Use of Non-GAAP Financial Measures” section for additional information.

GAAP for segment reporting requires that the total of the reportable segments’ measures of profit or loss be reconciled to the Company’s consolidated operating results. The following table reconciles Segment Adjusted EBITDA to consolidated net income for the three and nine months ended September 30, 2013 and 2012:


		Three Months Ended September 30,						Nine Months Ended September 30,
		2013			2012			2013			2012
SCM Adjusted EBITDA		$	47,387		$	46,340		$	144,041		$	132,846
RCM Adjusted EBITDA			15,349			17,835			47,061			41,532

Total reportable Segment Adjusted EBITDA			62,736			64,175			191,102			174,378
Depreciation			(8,244)			(5,224)			(21,890)			(14,459)
Depreciation (included in cost of revenue)			(571)			(536)			(1,740)			(1,353)
Amortization of intangibles			(15,341)			(17,840)			(47,957)			(55,251)
Amortization of intangibles (included in cost of revenue)			-			(139)			-			(417)
Interest expense, net of interest income(1)			-			-			-			5
Income tax expense			-13,184			(19,426)			(39,489)			(40,749)
Share-based compensation expense(2)			(2,486)			(1,221)			(6,408)			(3,943)
Acquisition and integration-related expenses(3)			(111)			(1,535)			(9,576)			(4,812)

Total reportable segment net income			22,799			18,254			64,042			53,399
Corporate net loss			(15,897)			(12,790)			(44,352)			(45,923)

Consolidated net income		$	6,902		$	5,464		$	19,690		$	7,476

	-1	Interest income is included in other income (expense) and is not netted against interest expense in our condensed consolidated statements of operations.

	-2	Represents non-cash share-based compensation to both employees and directors. We believe excluding this non-cash expense allows us to compare our operating performance without regard to the impact of share-based compensation, which varies from period to period based on amount and timing of grants.

	-3	Represents the amount attributable to acquisition and integration-related costs which include costs such as severance, retention, salaries relating to redundant positions, certain performance-related salary-based compensation, operating infrastructure costs and facility consolidation costs. We may incur costs in future periods related to our plans including but not limited to aligning service offerings and standardizing and migrating certain Broadlane operational systems and transactional data sets into our operational systems.

Derivative_Financial_Instrumen

Derivative Financial Instruments	9 Months Ended
Derivative Financial Instruments	Sep. 30, 2013
Derivative Instruments And Hedging Activities Disclosure [Abstract]	'
Derivative Financial Instruments	'
	11	DERIVATIVE FINANCIAL INSTRUMENTS
	We have interest rate risk relative to the outstanding borrowings under our credit agreement. Loans under the credit agreement bear interest, at the Company’s election, either at the prime rate or the London Interchange Bank Offering Rate (“LIBOR”) plus a percentage point spread based on certain specified financial ratios. The Company’s policy has been to manage interest cost using a mix of fixed and variable rate debt.
	On December 13, 2012, we terminated our two floating-to-fixed rate LIBOR-based forward starting interest rate swaps, originally entered into on May 5, 2011. The swaps were originally scheduled to fully terminate by February 2015. Such early termination was deemed to be a termination of all future obligations between us and each counterparty. In consideration of the early termination, we paid a total of $8,209 to the counterparties on December 17, 2012. We have no assets or liabilities remaining on our condensed consolidated balance sheet with respect to these interest rate swaps as of September 30, 2013 and December 31, 2012, respectively. For the three and nine months ended September 30, 2012, the effects of the derivative instruments designated as cash flow hedges on income and AOCI were as follows:


			Three Months Ended September 30,				Nine Months Ended September 30,
	Derivatives designated as cash flow hedges		2013		2012		2013		2012
	Total unrealized loss recognized in other comprehensive income - interest rate contracts		$	-	$	(178)	$	-	$	(921)
	Total realized loss reclassified into earnings - interest rate contracts		$	-		-	$	-		-

Fair_Value_Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]	'
Fair Value Measurements	'
	12. FAIR VALUE MEASUREMENTS
	We measure fair value for financial instruments when a valuation is necessary, such as for impairment of long-lived and indefinite-lived assets when indicators of impairment exist in accordance with GAAP for fair value measurements and disclosures. This defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measures required under other accounting pronouncements, but does not change existing guidance as to whether or not an instrument is carried at fair value.

	Refer to Note 11 for information and fair values of our derivative instruments measured on a recurring basis under GAAP for fair value measurements and disclosures.
	In estimating our fair value disclosures for financial instruments, we use the following methods and assumptions:

		—	Cash and cash equivalents: The carrying value reported in the condensed consolidated balance sheets for these items approximates fair value due to the high credit standing of the financial institutions holding these items and their liquid nature;

		—	Accounts receivable, net: The carrying value reported in the condensed consolidated balance sheets is net of allowances for doubtful accounts which includes a degree of counterparty non-performance risk;

		—	Accounts payable and current liabilities: The carrying value reported in the condensed consolidated balance sheets for these items approximates fair value, which is the likely amount for which the liability with short settlement periods would be transferred to a market participant with a similar credit standing as the Company;

		—	Notes payable: The carrying value of our long-term notes payable reported in the condensed consolidated balance sheets approximates fair value since they bear interest at variable rates. Refer to Note 5 for further information; and

		—	Bonds payable: The carrying value of our long-term bonds payable reported in the condensed consolidated balance sheets approximates fair value. Refer to Note 5 for further information.

Related_Party_Transaction

Related Party Transaction	9 Months Ended
	Sep. 30, 2013
Related Party Transactions [Abstract]	'
Related Party Transaction	'
	13	RELATED PARTY TRANSACTION
	We have an agreement with John Bardis, our chief executive officer, for the use of an airplane owned by JJB Aviation, LLC, a limited liability company, owned by Mr. Bardis. We pay Mr. Bardis at market-based rates for the use of the airplane for business purposes. The Audit Committee of the Board of Directors reviews such usage of the airplane annually. During the nine months ended September 30, 2013 and 2012, we incurred charges of $1,737 and $1,221, respectively, related to transactions with Mr. Bardis.

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	14	SUBSEQUENT EVENTS
	We have evaluated subsequent events for recognition or disclosure in the condensed consolidated financial statements filed on Form 10-Q with the SEC and no events have occurred that require disclosure.

Business_Description_and_Basis1

Business Description and Basis of Presentation (Policies)	9 Months Ended
Business Description and Basis of Presentation (Policies)	Sep. 30, 2013
Accounting Policies [Abstract]	'
Use of Estimates	'
	Use of Estimates
	The preparation of the financial statements and related disclosures in conformity with GAAP and pursuant to the rules and regulations of the SEC, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ materially from those estimates. We believe that the estimates, assumptions and judgments involved in revenue recognition, allowances for doubtful accounts and returns, product development costs, share-based payments, business combinations, impairment of goodwill, intangible assets and long-lived assets, and accounting for income taxes have the greatest potential impact on our condensed consolidated financial statements.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	All of our highly liquid investments with original maturities of three months or less at the date of purchase are carried at cost which approximates fair value and are considered to be cash equivalents. Currently, our excess cash is voluntarily used to repay our swing-line credit facility, if any, on a daily basis and applied against our revolving credit facility on a routine basis when our swing-line credit facility is undrawn. In addition, we may periodically make voluntary repayments on our term loans. Cash and cash equivalents were zero and $13,734 as of September 30, 2013 and December 31, 2012, respectively, and our swing-line balance was zero during those reporting periods. We had $10,000 outstanding on our revolving credit facility as of September 30, 2013 and December 31, 2012. In the event our cash balance is zero at the end of a period, any outstanding checks are recorded as accrued expenses. As of September 30, 2013, we reclassified approximately $4,686 of outstanding checks related to a book overdraft into other accrued expenses on the condensed consolidated balance sheet. This book overdraft amount has been included in operating activities within the condensed consolidated statement of cash flows. See Note 5 for immediately available cash under our revolving credit facility.
Income Taxes	'
	Income Taxes
	In July 2013, the Financial Accounting Standards Board (“FASB”) issued an accounting standard update relating to the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This update amends existing GAAP that required in certain cases, an unrecognized tax benefit, or portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward when such items exist in the same taxing jurisdiction. The amendments in this update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. Early adoption is permitted. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date, and retrospective application is permitted. We do not expect any impact from this update on our financial statements.
Comprehensive Income	'
	Comprehensive Income
	In February 2013, the FASB issued an accounting standard update relating to improving the reporting of reclassifications out of accumulated other comprehensive income. The update would require an entity to report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income if the amount being reclassified is required under GAAP to be reclassified in its entirety to net income. For other amounts that are not required under GAAP to be reclassified in their entirety to net income in the same reporting period, an entity is required to cross-reference other disclosures required under GAAP that provide additional detail about those amounts. The update is effective for reporting periods beginning after December 15, 2012. We adopted this update on January 1, 2013.

Acquisition_and_IntegrationRel1

Acquisition and Integration-Related Expenses (Tables)	9 Months Ended
Acquisition and Integration-Related Expenses (Tables)	Sep. 30, 2013
Text Block [Abstract]	'
Schedule of Restructuring Activities	'
	The following table summarizes the details of the Company’s restructuring activities during the nine months ended September 30, 2013:


		Employee-related		System migration		Facility		Total
		costs		and integration		consolidation		Total
	Restructuring Reserve
	Accrued, December 31, 2012	$	995	$	305	$	132	$	1,432
	Charges incurred		807		2,372		6,397		9,576
	Adjustments		-		(389)		613		224
	Cash payments		(1,105)		(2,280)		(7,142)		(10,527)

	Accrued, September 30, 2013	$	697	$	8	$	-	$	705	(1)

Deferred_Revenue_Tables

Deferred Revenue (Tables)	9 Months Ended
Deferred Revenue (Tables)	Sep. 30, 2013
Revenue Recognition [Abstract]	'
Summary of Deferred Revenue	'
	The following table summarizes the deferred revenue categories and balances as of:


		September 30,		December 31,
		2013		2012
	Software and implementation fees	$	26,313	$	24,468
	Service fees		28,890		26,135
	Administrative fees		9,353		14,672
	Other fees		2,162		4,874

	Deferred revenue, total		66,718		70,149
	Less: Deferred revenue, current portion		(51,758)		(55,756)

	Deferred revenue, non-current portion	$	14,960	$	14,393

Notes_and_Bonds_Payable_Tables

Notes and Bonds Payable (Tables)	9 Months Ended
Notes and Bonds Payable (Tables)	Sep. 30, 2013
Debt Disclosure [Abstract]	'
Summary of Notes Payable	'
	The balances of our notes and bonds payable are summarized as follows as of:


			September 30,		December 31,
			2013		2012
	Term A facility		$	240,625	$	250,000
	Term B facility			217,750		300,000
	Revolving credit facility			10,000		10,000

	Total notes payable			468,375		560,000
	Bonds payable			325,000		325,000

	Total notes and bonds payable			793,375		885,000
	Less: current portions			(15,500)		(15,500)

	Total long-term notes and bonds payable		$	777,875	$	869,500

Percentage of Redemption Prices	'
	The Company has the option to redeem the Notes as follows: (i) at any time prior to November 15, 2014, the Company may redeem all or part of the Notes at a redemption price equal to 100% of the principal amount plus the applicable premium (as defined in the Indenture); (ii) at any time prior to November 15, 2013, the Company may redeem up to 35% of the aggregate principal amount of the Notes issued with the cash proceeds of one or more equity offerings at a redemption price of 108% of the principal amount, provided that: (A) at least 65% of the aggregate original principal amount of the Notes remains outstanding immediately after each such redemption; and (B) the redemption occurs within 60 days after the closing of such equity offering; and (iii) on and after November 15, 2014, the Company may redeem all or a part of the Notes, at the following redemption prices:


	Year		Percentage
	2014			104%
	2015			102%
	2016 and thereafter			100%
Debt Maturities and Scheduled Principal Repayments	'
	The following table summarizes our stated debt maturities and scheduled principal repayments as of September 30, 2013:


	Year		Term A Facility		Term B Facility		Revolving Credit		Senior		Total
	Year		Term A Facility		Term B Facility		Facility		Unsecured Notes		Total
	2013		$	3,125	$	750	$	-	$	-	$	3,875	(1)
	2014			12,500		3,000		-		-		15,500
	2015			18,750		3,000		-		-		21,750
	2016			25,000		3,000		-		-		28,000
	2017			181,250		3,000		10,000		-		194,250
	Thereafter			-		205,000		-		325,000		530,000

			$	240,625	$	217,750	$	10,000	$	325,000	$	793,375


		-1	Represents the remaining quarterly principal payments due during the fiscal year ending December 31, 2013.

Stockholders_Equity_and_ShareB1

Stockholders' Equity and Share-Based Compensation (Tables)	9 Months Ended
Stockholders' Equity and Share-Based Compensation (Tables)	Sep. 30, 2013
Text Block [Abstract]	'
Summary of Total Share-Based Compensation Expense	'
	Total share-based compensation expense (inclusive of restricted common stock, SSARs and common stock options) for the three and nine months ended September 30, 2013 and 2012 as reflected in our condensed consolidated statements of operations is as follows:


			Three Months Ended September 30,					Nine Months Ended September 30,
			2013			2012		2013		2012
	Cost of revenue		$	864		$	672	$	3,040	$	1,535
	Product development			130			34		473		123
	Selling and marketing			975			282		1,944		1,069
	General and administrative			2,392			1,793		6,326		5,069

	Total share-based compensation expense		$	4,361	(1)	$	2,781	$	11,783	$	7,796


	-1	For the three months ended September 30, 2013, share-based compensation includes charges related to the resignation of our RCM president and the conformity of one officer’s terms and conditions to their 2013 performance award grant.

Income_Per_Share_Tables

Income Per Share (Tables)	9 Months Ended
Income Per Share (Tables)	Sep. 30, 2013
Earnings Per Share [Abstract]	'
Reconciliation of Basic and Diluted Weighted Average Shares Outstanding	'
	A reconciliation of basic and diluted weighted average shares outstanding for basic and diluted EPS for the three and nine months ended September 30, 2013 and 2012 is as follows:


		Three Months Ended September 30,
		2013		2012
	Numerator for Basic and Diluted Income Per Share:
	Net income		6,902		5,464
	Denominator for basic income per share weighted average shares		59,936,000		57,693,000
	Effect of dilutive securities:
	Stock options		529,000		999,000
	Stock-settled stock appreciation rights		406,000		96,000
	Restricted stock and stock warrants		605,000		725,000

	Denominator for diluted income per share—adjusted weighted average shares and assumed conversions		61,476,000		59,513,000
	Basic income per share:
	Basic net income from continuing operations	$	0.12	$	0.09

	Diluted net income per share:
	Diluted net income from continuing operations	$	0.11	$	0.09



		Nine Months Ended September 30,
		2013		2012
	Numerator for Basic and Diluted Income Per Share:
	Net income		19,690		7,476
	Denominator for basic income per share weighted average shares		59,446,000		57,239,000
	Effect of dilutive securities:
	Stock options		601,000		916,000
	Stock-settled stock appreciation rights		285,000		15,000
	Restricted stock and stock warrants		580,000		726,000

	Denominator for diluted income per share—adjusted weighted average shares and assumed conversions		60,912,000		58,896,000
	Basic income per share:
	Basic net income from continuing operations	$	0.33	$	0.13

	Diluted net income per share:
	Diluted net income from continuing operations	$	0.32	$	0.13

Summary of Potentially Dilutive Securities	'
	The following table provides a summary of those potentially dilutive securities that have been excluded from the above calculation of diluted EPS:


		Three Months Ended September 30,				Nine Months Ended September 30,
		2013		2012		2013		2012
	Stock options		-		40,000		-		70,000
	Stock-settled stock appreciation rights		8,000		386,000		37,000		830,000
	Restricted stock and stock warrants		-		-		1,000		3,000

	Total		8,000		426,000		38,000		903,000

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
Segment Information (Tables)	Sep. 30, 2013
Segment Reporting [Abstract]	'
Financial Information of Business Segments	'
	The following tables represent our results of operations, by segment, for the three and nine months ended September 30, 2013 and 2012:


			Three Months Ended September 30, 2013
			SCM			RCM			Corporate			Total
	Results of Operations:
	Revenue:
	Gross administrative fees(1)		$	115,478		$	-		$	-		$	115,478
	Revenue share obligation(1)			(46,052)			-			-			(46,052)
	Other service fees			33,801			63,144			-			96,945

	Total net revenue			103,227			63,144			-			166,371
	Total operating expenses			74,381			56,016			13,393			143,790

	Operating income (loss)			28,846			7,128			(13,393)			22,581
	Interest expense			-			-			(11,814)			(11,814)
	Other (expense) income			1			7			110			118

	Income (loss) before income taxes		$	28,847		$	7,135		$	(25,097)		$	10,885
	Income tax expense (benefit)			10,599			2,584			(9,200)			3,983

	Net income (loss)			18,248			4,551			(15,897)			6,902

	Segment Adjusted EBITDA		$	47,387		$	15,349		$	(8,837)		$	53,899

		-1	These are non-GAAP measures. See “Use of Non-GAAP Financial Measures” section for additional information.


			As of September 30, 2013
			SCM			RCM			Corporate			Total
	Financial Position:
	Accounts receivable, net		$	39,489		$	51,647		$	16		$	91,152
	Other assets			965,833			503,063			74,558			1,543,454

	Total assets			1,005,322			554,710			74,574			1,634,606
	Accrued revenue share obligation			78,379			-			-			78,379
	Deferred revenue			25,424			41,294			-			66,718
	Notes payable			-			-			468,375			468,375
	Bonds payable			-			-			325,000			325,000
	Other liabilities			28,039			25,156			164,124			217,319

	Total liabilities		$	131,842		$	66,450		$	957,499		$	1,155,791


			Three Months Ended September 30, 2012
			SCM			RCM			Corporate			Total
	Results of Operations:
	Revenue:
	Gross administrative fees(1)		$	109,335		$	-		$	-		$	109,335
	Revenue share obligation(1)			(40,694)			-			-			(40,694)
	Other service fees			30,471			64,329			-			94,800

	Total net revenue			99,112			64,329			-			163,441
	Total operating expenses			72,715			53,082			11,236			137,033

	Operating income (loss)			26,397			11,247			(11,236)			26,408
	Interest expense			-			-			(16,672)			(16,672)
	Other income			9			27			78			114

	Income (loss) before income taxes		$	26,406		$	11,274		$	(27,830)		$	9,850
	Income tax expense (benefit)			14,255			5,171			(15,040)			4,386

	Net income (loss)			12,151			6,103			(12,790)			5,464

Segment Adjusted EBITDA		$	46,340		$	17,835		$	(7,210)		$	56,965

	-1	These are non-GAAP measures. See “Use of Non-GAAP Financial Measures” section for additional information.


		Nine Months Ended September 30, 2013
		SCM			RCM			Corporate			Total
Results of Operations:
Revenue:
Gross administrative fees(1)		$	351,602		$	-		$	-		$	351,602
Revenue share obligation(1)			(135,155)			-			-			(135,155)
Other service fees			101,596			191,907			-			293,503

Total net revenue			318,043			191,907			-			509,950
Total operating expenses			238,777			167,593			36,640			443,010

Operating income (loss)			79,266			24,314			(36,640)			66,940
Interest expense			-			-			(35,544)			(35,544)
Other (expense) income			(28)			(22)			485			435

Income (loss) before income taxes		$	79,238		$	24,292		$	(71,699)		$	31,831
Income tax expense (benefit)			30,222			9,266			(27,347)			12,141

Net income (loss)			49,016			15,026			(44,352)			19,690

Segment Adjusted EBITDA		$	144,041		$	47,061		$	(23,020)		$	168,082

	-1	These are non-GAAP measures. See “Use of Non-GAAP Financial Measures” section for additional information.


		Nine Months Ended September 30, 2012
		SCM			RCM			Corporate			Total
Results of Operations:
Revenue:
Gross administrative fees(1)		$	321,351		$	-		$	-		$	321,351
Revenue share obligation(1)			(120,599)			-			-			(120,599)
Other service fees			93,740			181,849			-			275,589

Total net revenue			294,492			181,849			-			476,341
Total operating expenses			220,938			161,273			32,914			415,125

Operating income (loss)			73,554			20,576			(32,914)			61,216
Interest expense			-			-			(50,722)			(50,722)
Other (expense) income			(12)			30			431			449

Income (loss) before income taxes		$	73,542		$	20,606		$	(83,205)		$	10,943
Income tax expense (benefit)			31,830			8,919			(37,282)			3,467

Net income (loss)			41,712			11,687			(45,923)			7,476

Segment Adjusted EBITDA		$	132,846		$	41,532		$	(22,001)		$	152,377

	-1	These are non-GAAP measures. See “Use of Non-GAAP Financial Measures” section for additional information.
Segment Adjusted EBITDA to Consolidated Net (Loss) Income	'
	The following table reconciles Segment Adjusted EBITDA to consolidated net income for the three and nine months ended September 30, 2013 and 2012:


			Three Months Ended September 30,						Nine Months Ended September 30,
			2013			2012			2013			2012
	SCM Adjusted EBITDA		$	47,387		$	46,340		$	144,041		$	132,846
	RCM Adjusted EBITDA			15,349			17,835			47,061			41,532

	Total reportable Segment Adjusted EBITDA			62,736			64,175			191,102			174,378
	Depreciation			(8,244)			(5,224)			(21,890)			(14,459)
	Depreciation (included in cost of revenue)			(571)			(536)			(1,740)			(1,353)
	Amortization of intangibles			(15,341)			(17,840)			(47,957)			(55,251)
	Amortization of intangibles (included in cost of revenue)			-			(139)			-			(417)
	Interest expense, net of interest income(1)			-			-			-			5
	Income tax expense			-13,184			(19,426)			(39,489)			(40,749)
	Share-based compensation expense(2)			(2,486)			(1,221)			(6,408)			(3,943)
	Acquisition and integration-related expenses(3)			(111)			(1,535)			(9,576)			(4,812)

	Total reportable segment net income			22,799			18,254			64,042			53,399
	Corporate net loss			(15,897)			(12,790)			(44,352)			(45,923)

	Consolidated net income		$	6,902		$	5,464		$	19,690		$	7,476

		-1	Interest income is included in other income (expense) and is not netted against interest expense in our condensed consolidated statements of operations.

		-2	Represents non-cash share-based compensation to both employees and directors. We believe excluding this non-cash expense allows us to compare our operating performance without regard to the impact of share-based compensation, which varies from period to period based on amount and timing of grants.

		-3	Represents the amount attributable to acquisition and integration-related costs which include costs such as severance, retention, salaries relating to redundant positions, certain performance-related salary-based compensation, operating infrastructure costs and facility consolidation costs. We may incur costs in future periods related to our plans including but not limited to aligning service offerings and standardizing and migrating certain Broadlane operational systems and transactional data sets into our operational systems.

Derivative_Financial_Instrumen1

Derivative Financial Instruments (Tables)	9 Months Ended
Derivative Financial Instruments (Tables)	Sep. 30, 2013
Derivative Instruments And Hedging Activities Disclosure [Abstract]	'
Derivative Instruments Designated as Cash Flow Hedges on Income and AOCI	'
	For the three and nine months ended September 30, 2012, the effects of the derivative instruments designated as cash flow hedges on income and AOCI were as follows:


		Three Months Ended September 30,				Nine Months Ended September 30,
	Derivatives designated as cash flow hedges	2013		2012		2013		2012
	Total unrealized loss recognized in other comprehensive income - interest rate contracts	$	-	$	(178)	$	-	$	(921)
	Total realized loss reclassified into earnings - interest rate contracts	$	-		-	$	-		-

Business_Description_and_Basis2

Business Description and Basis of Presentation - Additional Information (Detail) (USD $)	9 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
Accounting Policies [Abstract]	'	'	'	'
Maturity period of liquid instruments	'Three months or less	'	'	'
Cash and cash equivalents	$0	$13,734	$8,234	$62,947
Swing-line balance	0	0	'	'
Revolving credit facility	10,000	10,000	'	'
Outstanding checks recorded as accrued expenses	0	0	'	'
Outstanding checks related to a book overdraft into other accrued expenses	$4,686	'	'	'

Acquisition_and_IntegrationRel2

Acquisition and Integration-Related Expenses - Additional Information (Detail) (USD $)

1 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

In Thousands, unless otherwise specified

Mar. 31, 2013

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Aug. 31, 2013

Mar. 31, 2013

Sep. 30, 2013

Jan. 31, 2012

Sep. 30, 2013

sqft

Employee-related Costs [Member]

System Migration and Integration [Member]

Facility Consolidation [Member]

Broadlane Acquisition [Member]

Facility Consolidation [Member]

Restructuring Acquisition And Integration Charges [Line Items]

Balance of deferred purchase consideration

$120,136

Charges incurred

111

1,535

9,576

4,812

807

2,372

6,924

6,397

Cash compensation and other employee benefit cost

570

Share based compensation and other employee benefit cost

920

Severance and other employee benefits cost

738

807

2,587

787

2,372

2,175

Current liabilities on Severance and other employee benefits cost

697

Impaired development projects write-off

-389

Area of office space

231,000

Initial term of lease agreement

'Fifteen years plus

Extension period for lease agreement

'10 years

Tenant allowance included in property and equipment

10,378

Property and equipment

155,485

134,361

9,974

Allowance included in other accrued expenses

23,562

14,145

692

Allowance included in other long term liabilities

10,119

801

9,282

Lease agreement expiration date

'2013-08

Lease agreement termination date

'2022-01

Lease termination fee

6,000

Total exit cost

-557

Non-cash adjustment of accrued rent

613

Previously accrued rent

1,669

Facility assets write off

($1,056)

Acquisition_and_IntegrationRel3

Acquisition and Integration-Related Expenses - Schedule of Restructuring Activities (Detail) (USD $)	3 Months Ended		9 Months Ended				1 Months Ended	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2013	Mar. 31, 2013	Sep. 30, 2013
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Employee-related Costs [Member]	System Migration and Integration [Member]	Facility Consolidation [Member]	Facility Consolidation [Member]
Restructuring Cost and Reserve [Line Items]	'	'	'	'	'	'	'	'
Restructuring Reserve Accrued, Beginning Balance	'	'	$1,432	'	$995	$305	'	$132
Charges incurred	111	1,535	9,576	4,812	807	2,372	6,924	6,397
Adjustments	'	'	224	'	'	-389	'	613
Cash payments	'	'	-10,527	'	-1,105	-2,280	'	-7,142
Restructuring Reserve Accrued, Ending Balance	$705	'	$705	'	$697	$8	'	'

Deferred_Revenue_Summary_of_De

Deferred Revenue - Summary of Deferred Revenue (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Deferred Revenue Arrangement [Line Items]	'	'
Deferred revenue, total	$66,718	$70,149
Less: Deferred revenue, current portion	-51,758	-55,756
Deferred revenue, non-current portion	14,960	14,393
Software and Implementation Fees [Member]	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Deferred revenue, total	26,313	24,468
Service Fees [Member]	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Deferred revenue, total	28,890	26,135
Administrative Fees [Member]	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Deferred revenue, total	9,353	14,672
Other Fees [Member]	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Deferred revenue, total	$2,162	$4,874

Deferred_Revenue_Additional_In

Deferred Revenue - Additional Information (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Text Block [Abstract]	'	'
Contingent deferred revenue	$8,318	$8,284

Notes_and_Bonds_Payable_Summar

Notes and Bonds Payable - Summary of Notes Payable (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Debt Instrument [Line Items]	'	'
Total notes payable	$468,375	$560,000
Bonds payable	325,000	325,000
Total notes and bonds payable	793,375	885,000
Less: current portions	-15,500	-15,500
Total long-term notes and bonds payable	777,875	869,500
Term A Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Total notes payable	240,625	250,000
Total notes and bonds payable	240,625	'
Term B Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Total notes payable	217,750	300,000
Total notes and bonds payable	217,750	'
Revolving Credit Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Total notes payable	10,000	10,000
Total notes and bonds payable	$10,000	'

Notes_and_Bonds_Payable_Additi

Notes and Bonds Payable - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Debt Instrument [Line Items]	'	'	'	'
Notes payable	$468,375	'	$468,375	'
Amount drawn on revolving credit facility	10,000	'	10,000	'
Outstanding letter of credit under credit facility	189,000	'	189,000	'
Undrawn letters of credit outstanding amount	1,000	'	1,000	'
Scheduled principal payments	'	'	11,625	'
Debt issuance costs	18,214	'	'	'
Amortization of debt issuance costs	951	1,914	2,858	5,705
Total interest paid	'	'	28,038	37,563
Term A Facility [Member]	'	'	'	'
Debt Instrument [Line Items]	'	'	'	'
Notes payable	240,625	'	240,625	'
Weighted average interest rate of senior term loan facility	2.53%	'	2.53%	'
Term B Facility [Member]	'	'	'	'
Debt Instrument [Line Items]	'	'	'	'
Notes payable	217,750	'	217,750	'
Voluntary prepayment on Term B Facility	'	'	80,000	'
Weighted average interest rate of senior term loan facility	4.00%	'	4.00%	'
Revolving Credit Facility [Member]	'	'	'	'
Debt Instrument [Line Items]	'	'	'	'
Notes payable	10,000	'	10,000	'
Maturity date of debt instrument	'	'	13-Dec-17	'
Weighted average interest rate of senior term loan facility	2.52%	'	2.52%	'
Debt Instrument, Redemption, Period One [Member]	'	'	'	'
Debt Instrument [Line Items]	'	'	'	'
Percentage of Principal Amount for Redemption price	'	'	100.00%	'
Debt Instrument, Redemption, Period Two [Member]	'	'	'	'
Debt Instrument [Line Items]	'	'	'	'
Percentage of Principal Amount for Redemption price	'	'	108.00%	'
Minimum Aggregate Principle Amount	'	'	65.00%	'
Closing Of Equity Offering	'	'	'60 days	'
Senior Notes Due 2018 [Member]	'	'	'	'
Debt Instrument [Line Items]	'	'	'	'
Maturity date of debt instrument	'	'	15-Nov-18	'
Principal amount of senior notes	$325,000	'	$325,000	'
Percentage owned by subsidiary guarantor	100.00%	'	100.00%	'
Percentage of interest rate on bonds payable	8.00%	'	8.00%	'
Percentage of Redemption of Notes Issued	'	'	35.00%	'
Repurchase percentage of aggregate principal amount plus accrued and unpaid interest	101.00%	'	101.00%	'
Percentage of par value on senior notes	'	'	107.50%	'

Notes_and_Bonds_Payable_Percen

Notes and Bonds Payable - Percentage of Redemption Prices (Detail) (Senior Notes Due 2018 [Member])	9 Months Ended
	Sep. 30, 2013
Senior Notes Due 2018 [Member]	'
Debt Instrument [Line Items]	'
2014	104.00%
2015	102.00%
2016 and thereafter	100.00%

Notes_and_Bonds_Payable_Debt_M

Notes and Bonds Payable - Debt Maturities and Scheduled Principal Repayments (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Debt Instrument [Line Items]	'	'
Principal Payment in 2013	$3,875	'
Principal Payment in 2014	15,500	'
Principal Payment in 2015	21,750	'
Principal Payment in 2016	28,000	'
Principal Payment in 2017	194,250	'
Thereafter	530,000	'
Total notes and bonds payable	793,375	885,000
Term A Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Principal Payment in 2013	3,125	'
Principal Payment in 2014	12,500	'
Principal Payment in 2015	18,750	'
Principal Payment in 2016	25,000	'
Principal Payment in 2017	181,250	'
Thereafter	'	'
Total notes and bonds payable	240,625	'
Term B Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Principal Payment in 2013	750	'
Principal Payment in 2014	3,000	'
Principal Payment in 2015	3,000	'
Principal Payment in 2016	3,000	'
Principal Payment in 2017	3,000	'
Thereafter	205,000	'
Total notes and bonds payable	217,750	'
Revolving Credit Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Principal Payment in 2013	'	'
Principal Payment in 2014	'	'
Principal Payment in 2015	'	'
Principal Payment in 2016	'	'
Principal Payment in 2017	10,000	'
Thereafter	'	'
Total notes and bonds payable	10,000	'
Senior Unsecured Notes [Member]	'	'
Debt Instrument [Line Items]	'	'
Principal Payment in 2013	'	'
Principal Payment in 2014	'	'
Principal Payment in 2015	'	'
Principal Payment in 2016	'	'
Principal Payment in 2017	'	'
Thereafter	325,000	'
Total notes and bonds payable	$325,000	'

Stockholders_Equity_and_ShareB2

Stockholders' Equity and Share-Based Compensation - Additional Information (Detail) (USD $)

3 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

In Thousands, except Share data, unless otherwise specified

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2010

Sep. 30, 2013

Plans

Restricted Shares [Member]

Service-Based Restricted Shares Vesting Each Month Through December 31, 2013 [Member]

Service-Based Restricted Shares [Member]

Performance-Based Restricted Shares [Member]

Performance-Based Restricted Shares Using EBITDA Performance Metric [Member]

Employee Stock Purchase Plan [Member]

SSARS Awards [Member]

Long Term Incentive Plan [Member]

Restricted Common Stock Awards [Member]

Common Stock Option Awards [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Equity [Line Items]

Stock issued in connection with exercise of stock options

1,427,000

Aggregate exercise price of stock issued in connection with exercise of stock options

$9,911

Shares reserved under 2008 equity incentive plan available for grant

4,955,000

1,160,000

50,000

435,000

337,500

500,000

Number of share based compensation plans

Additional shares

38,000

2,600,000

Share-based compensation expense

4,361

2,781

11,783

7,796

Income tax benefit recognized from equity awards

1,627

1,033

4,396

2,895

Capitalized share-based compensation expenses

Percentage of price per share of the common stock sold to participating employees

95.00%

Period required for holding stock purchases as per the plan

'18 months

Shares of common stock purchased

24,700

25,400

Shares of common stock purchased, amount

$482

$372

Weighted average grant date fair value, Granted

$18.34

$20.03

Share-based payment award, award vesting period

'3 years

'5 years

Percentage to earn from performance-based equity awards

50.00%

100.00%

50.00%

100.00%

Restricted shares that surrendered from equity awards holders

54,000

Forfeited, Shares

245,000

69,000

Total unrecognized compensation expense

$3,179

$13,188

$64

Total unrecognized compensation expense will be recognized over a weighted-average period

'1 year 7 months 6 days

'1 year 3 months 18 days

'1 year

Common stock granted

3,000

Weighted average grant date base price

$16.77

Weighted-average fair value of each stock option awards

$7.15

Underlying shares of stock options forfeited

58,000

Stockholders_Equity_and_ShareB3

Stockholders' Equity and Share-Based Compensation - Summary of Total Share-Based Compensation Expense (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Shareholders Equity And Share Based Payments [Line Items]	'	'	'	'
Total share-based compensation expense	$4,361	$2,781	$11,783	$7,796
Cost of Revenue [Member]	'	'	'	'
Shareholders Equity And Share Based Payments [Line Items]	'	'	'	'
Total share-based compensation expense	864	672	3,040	1,535
Product Development [Member]	'	'	'	'
Shareholders Equity And Share Based Payments [Line Items]	'	'	'	'
Total share-based compensation expense	130	34	473	123
Selling and Marketing [Member]	'	'	'	'
Shareholders Equity And Share Based Payments [Line Items]	'	'	'	'
Total share-based compensation expense	975	282	1,944	1,069
General and Administrative [Member]	'	'	'	'
Shareholders Equity And Share Based Payments [Line Items]	'	'	'	'
Total share-based compensation expense	$2,392	$1,793	$6,326	$5,069

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Income Tax Disclosure [Abstract]	'	'	'	'
Effective income tax rate	36.60%	44.50%	38.10%	31.70%
Discrete tax benefit	'	'	'	$1,400

Income_Per_Share_Reconciliatio

Income Per Share - Reconciliation of Basic and Diluted Weighted Average Shares Outstanding (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Numerator for Basic and Diluted Income Per Share:	'	'	'	'
Net income	$6,902	$5,464	$19,690	$7,476
Denominator for basic income per share weighted average shares	59,936,000	57,693,000	59,446,000	57,239,000
Effect of dilutive securities:	'	'	'	'
Stock options	529,000	999,000	601,000	916,000
Stock-settled stock appreciation rights	406,000	96,000	285,000	15,000
Restricted stock and stock warrants	605,000	725,000	580,000	726,000
Denominator for diluted income per share-adjusted weighted average shares and assumed conversions	61,476,000	59,513,000	60,912,000	58,896,000
Basic income per share:	'	'	'	'
Basic net income from continuing operations	$0.12	$0.09	$0.33	$0.13
Diluted net income per share:	'	'	'	'
Diluted net income from continuing operations	$0.11	$0.09	$0.32	$0.13

Income_Per_Share_Summary_of_Po

Income Per Share - Summary of Potentially Dilutive Securities (Detail)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Potentially dilutive securities	8,000	426,000	38,000	903,000
Stock Options [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Potentially dilutive securities	'	40,000	'	70,000
Stock-Settled Stock Appreciation Rights [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Potentially dilutive securities	8,000	386,000	37,000	830,000
Restricted Stock and Stock Warrants [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Potentially dilutive securities	'	'	1,000	3,000

Segment_Information_Financial_

Segment Information - Financial Information of Business Segments (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Revenue:	'	'	'	'	'
Gross administrative fees	$115,478	$109,335	$351,602	$321,351	'
Revenue share obligation	-46,052	-40,694	-135,155	-120,599	'
Other service fees	96,945	94,800	293,503	275,589	'
Total net revenue	166,371	163,441	509,950	476,341	'
Total operating expenses	143,790	137,033	443,010	415,125	'
Operating income (loss)	22,581	26,408	66,940	61,216	'
Interest (expense)	-11,814	-16,672	-35,544	-50,722	'
Other (expense) income	118	114	435	449	'
Income (loss) before income taxes	10,885	9,850	31,831	10,943	'
Income tax expense (benefit)	3,983	4,386	12,141	3,467	'
Net income (loss)	6,902	5,464	19,690	7,476	'
Segment Adjusted EBITDA	53,899	56,965	168,082	152,377	'
Financial Position:	'	'	'	'	'
Accounts receivable, net	91,152	'	91,152	'	96,346
Other assets	1,543,454	'	1,543,454	'	'
Total assets	1,634,606	'	1,634,606	'	1,678,237
Accrued revenue share obligation	78,379	'	78,379	'	74,274
Deferred revenue	66,718	'	66,718	'	70,149
Notes payable	468,375	'	468,375	'	'
Bonds payable	325,000	'	325,000	'	325,000
Other liabilities	217,319	'	217,319	'	'
Total liabilities	1,155,791	'	1,155,791	'	1,244,614
SCM [Member]	'	'	'	'	'
Revenue:	'	'	'	'	'
Gross administrative fees	115,478	109,335	351,602	321,351	'
Revenue share obligation	-46,052	-40,694	-135,155	-120,599	'
Other service fees	33,801	30,471	101,596	93,740	'
Total net revenue	103,227	99,112	318,043	294,492	'
Total operating expenses	74,381	72,715	238,777	220,938	'
Operating income (loss)	28,846	26,397	79,266	73,554	'
Interest (expense)	'	'	'	'	'
Other (expense) income	1	9	-28	-12	'
Income (loss) before income taxes	28,847	26,406	79,238	73,542	'
Income tax expense (benefit)	10,599	14,255	30,222	31,830	'
Net income (loss)	18,248	12,151	49,016	41,712	'
Segment Adjusted EBITDA	47,387	46,340	144,041	132,846	'
Financial Position:	'	'	'	'	'
Accounts receivable, net	39,489	'	39,489	'	'
Other assets	965,833	'	965,833	'	'
Total assets	1,005,322	'	1,005,322	'	'
Accrued revenue share obligation	78,379	'	78,379	'	'
Deferred revenue	25,424	'	25,424	'	'
Notes payable	'	'	'	'	'
Bonds payable	'	'	'	'	'
Other liabilities	28,039	'	28,039	'	'
Total liabilities	131,842	'	131,842	'	'
RCM [Member]	'	'	'	'	'
Revenue:	'	'	'	'	'
Gross administrative fees	'	'	'	'	'
Revenue share obligation	'	'	'	'	'
Other service fees	63,144	64,329	191,907	181,849	'
Total net revenue	63,144	64,329	191,907	181,849	'
Total operating expenses	56,016	53,082	167,593	161,273	'
Operating income (loss)	7,128	11,247	24,314	20,576	'
Interest (expense)	'	'	'	'	'
Other (expense) income	7	27	-22	30	'
Income (loss) before income taxes	7,135	11,274	24,292	20,606	'
Income tax expense (benefit)	2,584	5,171	9,266	8,919	'
Net income (loss)	4,551	6,103	15,026	11,687	'
Segment Adjusted EBITDA	15,349	17,835	47,061	41,532	'
Financial Position:	'	'	'	'	'
Accounts receivable, net	51,647	'	51,647	'	'
Other assets	503,063	'	503,063	'	'
Total assets	554,710	'	554,710	'	'
Accrued revenue share obligation	'	'	'	'	'
Deferred revenue	41,294	'	41,294	'	'
Notes payable	'	'	'	'	'
Bonds payable	'	'	'	'	'
Other liabilities	25,156	'	25,156	'	'
Total liabilities	66,450	'	66,450	'	'
Corporate [Member]	'	'	'	'	'
Revenue:	'	'	'	'	'
Gross administrative fees	'	'	'	'	'
Revenue share obligation	'	'	'	'	'
Other service fees	'	'	'	'	'
Total net revenue	'	'	'	'	'
Total operating expenses	13,393	11,236	36,640	32,914	'
Operating income (loss)	-13,393	-11,236	-36,640	-32,914	'
Interest (expense)	-11,814	-16,672	-35,544	-50,722	'
Other (expense) income	110	78	485	431	'
Income (loss) before income taxes	-25,097	-27,830	-71,699	-83,205	'
Income tax expense (benefit)	-9,200	-15,040	-27,347	-37,282	'
Net income (loss)	-15,897	-12,790	-44,352	-45,923	'
Segment Adjusted EBITDA	-8,837	-7,210	-23,020	-22,001	'
Financial Position:	'	'	'	'	'
Accounts receivable, net	16	'	16	'	'
Other assets	74,558	'	74,558	'	'
Total assets	74,574	'	74,574	'	'
Accrued revenue share obligation	'	'	'	'	'
Deferred revenue	'	'	'	'	'
Notes payable	468,375	'	468,375	'	'
Bonds payable	325,000	'	325,000	'	'
Other liabilities	164,124	'	164,124	'	'
Total liabilities	$957,499	'	$957,499	'	'

Segment_Information_Segment_Ad

Segment Information - Segment Adjusted Ebitda Consolidated Net (Loss) Income (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'
Total reportable Segment Adjusted EBITDA	$62,736	$64,175	$191,102	$174,378
Depreciation	-10,926	-7,721	-29,979	-21,416
Net (loss) income	6,902	5,464	19,690	7,476
Amortization of intangibles	-15,341	-17,840	-47,957	-55,251
Income tax expense	3,983	4,386	12,141	3,467
Share-based compensation expense	-4,361	-2,781	-11,783	-7,796
SCM [Member]	'	'	'	'
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'
Total reportable Segment Adjusted EBITDA	47,387	46,340	144,041	132,846
Net (loss) income	18,248	12,151	49,016	41,712
Income tax expense	10,599	14,255	30,222	31,830
RCM [Member]	'	'	'	'
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'
Total reportable Segment Adjusted EBITDA	15,349	17,835	47,061	41,532
Net (loss) income	4,551	6,103	15,026	11,687
Income tax expense	2,584	5,171	9,266	8,919
Segment Reporting Reconciling Items [Member]	'	'	'	'
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'
Depreciation	-8,244	-5,224	-21,890	-14,459
Depreciation (included in cost of revenue)	-571	-536	-1,740	-1,353
Amortization of intangibles	-15,341	-17,840	-47,957	-55,251
Amortization of intangibles (included in cost of revenue)	'	-139	'	-417
Interest expense, net of interest income	'	'	'	5
Income tax expense	-13,184	-19,426	-39,489	-40,749
Share-based compensation expense	-2,486	-1,221	-6,408	-3,943
Acquisition and integration-related expenses	-111	-1,535	-9,576	-4,812
Reportable Segment [Member]	'	'	'	'
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'
Net (loss) income	22,799	18,254	64,042	53,399
Corporate [Member]	'	'	'	'
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'
Net (loss) income	-15,897	-12,790	-44,352	-45,923
Income tax expense	($9,200)	($15,040)	($27,347)	($37,282)

Derivative_Financial_Instrumen2

Derivative Financial Instruments - Additional Information (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012	Sep. 30, 2013	Dec. 31, 2012
	Dec. 31, 2012	Interest Rate Swap [Member]	Interest Rate Swap [Member]
Derivative [Line Items]	'	'	'
Expenses paid to counter parties	$8,209	'	'
Assets or liabilities remaining with respect to interest rate swaps	'	$0	$0

Derivative_Financial_Instrumen3

Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges on Income and AOCI (Detail) (Cash Flow Hedging [Member], Interest Rate Contract [Member], USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Cash Flow Hedging [Member] \| Interest Rate Contract [Member]	'	'	'	'
Derivatives, Fair Value [Line Items]	'	'	'	'
Total unrealized loss recognized in other comprehensive income - interest rate contracts	'	($178)	'	($921)
Total realized loss reclassified into earnings - interest rate contracts	'	'	'	'

Related_Party_Transaction_Addi

Related Party Transaction - Additional Information (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2012
Related Party Transactions [Abstract]	'	'
Charges incurred with respect to transactions with Mr. Bardis	$1,737	$1,221